Abstract
Tumors result from the imbalance between cell growth and apoptosis. One of the characteristic changes in cancers is the abnormality in cytoskeleton, which suggests some roles of cytoskeletal proteins in tumorigenesis or the maintenance of tumor cells. Previously we showed that cytoskeletal actin is the substrate of caspases, the proteases responsible for apoptosis, while the role of actin cleavage in apoptosis remained unknown. To examine the cleavage of actin in vivo, we extensively performed immunoblot analysis using actin fragment-specific antibody. Here, we showed that, in some solid tumor cells, induction of apoptosis was accompanied by caspase-dependent actin-cleavage to 15 and 31 kDa fragments in vivo. To elucidate the role of actin-cleavage further, we introduced actin cleaved-fragments. We found that ectopic expression of an actin 15 kDa fragment induces morphological changes resembling those of apoptotic cells. The expression of the actin fragment induced a dramatic change of cellular actin localization, as visualized by enhanced green fluorescent protein (EGFP)-tagged actin, while the actin fragment expression did not cause caspase activation nor the cleavage of a marker substrate protein, poly (ADP-ribose) polymerase. These results indicate that actin cleavage could play a positive role in the morphological changes of apoptosis downstream of caspase activation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alnemri ES. . 1997 J. Cell. Biochem. 64: 33–42.
Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW and Yuan J. . 1996 Cell 87: 171.
Asch HL, Head K, Dong Y, Natoli F, Winston JS, Connolly JL and Asch BB. . 1996 Cancer Res. 56: 4841–4845.
Brancolini C, Benedetti M and Schneider C. . 1995 EMBO J. 14: 5179–5190.
Brancolini C, Lazarevic D, Rodriguez J and Schneider C. . 1997 J. Cell. Biol. 139: 759–771.
Chaponnier C and Gabbiani G. . 1989 Am. J. Pathol. 134: 597–603.
Chen Z, Naito M, Mashima T and Tsuruo T. . 1996 Cancer Res. 56: 5224–5229.
Chinnaiyan AM, Chaudhary D, O'Rourke K, Koonin EV and Dixit VM. . 1997a Nature 388: 728–729.
Chinnaiyan AM, O'Rourke K, Lane BR and Dixit VM. . 1997b Science 275: 1122–1126.
Cotter TG, Lennon SV, Glynn JM and Green DR. . 1992 Cancer Res. 52: 997–1005.
Cryns VL, Bergeron L, Zhu H, Li H and Yuan J. . 1996 J. Biol. Chem. 271: 31277–31282.
Dolle RE, Hoyer D, Prasad CV, Schmidt SJ, Helaszek CT, Miller RE and Ator MA. . 1994 J. Med. Chem. 37: 563–564.
Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A and Nagata S. . 1998 Nature 391: 43–50.
Hengartner MO and Horvitz HR. . 1994 Curr. Opin. Genet. Dev. 4: 581–586.
Kayalar C, Ord T, Testa M, Zhong LT and Bredesen DE. . 1996 Proc. Natl. Acad. Sci. USA 93: 2234–2238.
Kerr JF, Wyllie AH and Currie AR. . 1972 Br. J. Cancer 26: 239–257.
Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, McGarry TJ, Kirschner MW, Koths K, Kwiatkowski DJ and Williams LT. . 1997 Science 278: 294–298.
Kumar S. . 1995 Trends Biochem. Sci. 20: 198–202.
Lazebnik YA, Takahashi A, Moir RD, Goldman RD, Poirier GG, Kaufmann SH and Earnshaw WC. . 1995 Proc. Natl. Acad. Sci. USA 92: 9042–9046.
Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES and Wang X. . 1997 Cell 91: 479–489.
Liu X, Kim CN, Yang J, Jemmerson R and Wang X. . 1996 Cell 86: 147–157.
Liu X, Zou H, Slaughter C and Wang X. . 1997 Cell 89: 175–184.
Martin SJ, Finucane DM, Amarante-Mendes GP, O'Brien GA and Green DR. . 1996 J. Biol. Chem. 271: 28753–28756.
Martin SJ, O'Brien GA, Nishioka WK, McGahon AJ, Mahboubi A, Saido TC and Green DR. . 1995 J. Biol. Chem. 270: 6425–6428.
Mashima T, Naito M, Fujita N, Noguchi K and Tsuruo T. . 1995a Biochem. Biophys. Res. Commun. 217: 1185–1192.
Mashima T, Naito M, Kataoka S, Kawai H and Tsuruo T. . 1995b Biochem. Biophys. Res. Commun. 209: 907–915.
Mashima T, Naito M, Noguchi K, Miller DK, Nicholson DW and Tsuruo T. . 1997 Oncogene 14: 1007–1012.
McCarthy NJ, Whyte MK, Gilbert CS and Evan GI. . 1997 J. Cell. Biol. 136: 215–227.
Mills JC, Stone NL, Erhardt J and Pittman RN. . 1998 J. Cell. Biol. 140: 627–636.
Naito M, Nagashima K, Mashima T and Tsuruo T. . 1997 Blood 89: 2060–2066.
Neamati N, Fernandez A, Wright S, Kiefer J and McConkey DJ. . 1995 J. Immunol. 154: 3788–3795.
Nicholson DW and Thornberry NA. . 1997 Trends Biochem. Sci. 22: 299–306.
Rao L, Perez D and White E. . 1996 J. Cell. Biol. 135: 1441–1455.
Rudel T and Bokoch GM. . 1997 Science 276: 1571–1574.
Sakahira H, Enari M and Nagata S. . 1998 Nature 391: 96–99.
Shiratsuchi A, Umeda M, Ohba Y and Nakanishi Y. . 1997 J. Biol. Chem. 272: 2354–2358.
Tanaka M, Mullauer L, Ogiso Y, Fujita H, Moriya S, Furuuchi K, Harabayashi T, Shinohara N, Koyanagi T and Kuzumaki N. . 1995 Cancer Res. 55: 3228–3232.
Toyoshima F, Moriguchi T and Nishida E. . 1997 J. Cell. Biol. 139: 1005–1015.
Tsujimoto Y and Croce CM. . 1985 Science 228: 1440–1443.
Vandekerckhove J, Leavitt J, Kakunaga T and Weber K. . 1980 Cell 22: 893–899.
Westphal M, Jungbluth A, Heidecker M, Muhlbauer B, Heizer C, Schwartz JM, Marriott G and Gerisch G. . 1997 Curr. Biol. 7: 176–183.
Wong WW. . 1998 Agents Actions 49: 5–13.
Wyllie AH. . 1980 Nature 284: 555–556.
Yuan J. . 1997 Curr. Opin. Cell. Biol. 9: 247–251.
Yuan J, Shaham S, Ledoux S, Ellis HM and Horvitz HR. . 1993 Cell 75: 641–652.
Zou H, Henzel WJ, Liu X, Lutschg A and Wang X. . 1997 Cell 90: 405–413.
Acknowledgements
We are grateful to Drs Akihiro Tomida and Naoya Fujita for technical advice. We also thank Drs Shingo Dan, Naomi Haga and Zhihong Chen for helpful discussions. This work was supported by the Organization for Pharmaceutical Safety and Research (OPSR), Japan, Grants-in-Aid for Cancer Research and Scientific Research from the Ministry of Education, Science and Culture, and a grant from the Vehicle Racing Commemorative Foundation, Japan.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mashima, T., Naito, M. & Tsuruo, T. Caspase-mediated cleavage of cytoskeletal actin plays a positive role in the process of morphological apoptosis. Oncogene 18, 2423–2430 (1999). https://doi.org/10.1038/sj.onc.1202558
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202558
Keywords
This article is cited by
-
Honokiol induces apoptosis-like death in Cryptocaryon irritans Tomont
Parasites & Vectors (2023)
-
Protein disulfide isomerase-mediated apoptosis and proliferation of vascular smooth muscle cells induced by mechanical stress and advanced glycosylation end products result in diabetic mouse vein graft atherosclerosis
Cell Death & Disease (2017)
-
Metacaspases versus caspases in development and cell fate regulation
Cell Death & Differentiation (2017)
-
Converging roles of caspases in inflammasome activation, cell death and innate immunity
Nature Reviews Immunology (2016)
-
Caspase-11 and caspase-1 differentially modulate actin polymerization via RhoA and Slingshot proteins to promote bacterial clearance
Scientific Reports (2015)